PharmAgents: Building a Virtual Pharma with Large Language Model Agents
The discovery of novel small molecule drugs remains a critical scientific challenge with far-reaching implications for treating diseases and advancing human health. Traditional drug development--especially for small molecule therapeutics--is a highly complex, resource-intensive, and time-consuming process that requires multidisciplinary collaboration. Recent breakthroughs in artificial intelligence (AI), particularly the rise of large language models (LLMs), present a transformative opportunity to streamline and accelerate this process. In this paper, we introduce PharmAgents, a virtual pharmaceutical ecosystem driven by LLM-based multi-agent collaboration. PharmAgents simulates the full drug discovery workflow--from target discovery to preclinical evaluation--by integrating explainable, LLM-driven agents equipped with specialized machine learning models and computational tools. Through structured knowledge exchange and automated optimization, PharmAgents identifies potential therapeutic targets, discovers promising lead compounds, enhances binding affinity and key molecular properties, and performs in silico analyses of toxicity and synthetic feasibility. Additionally, the system supports interpretability, agent interaction, and self-evolvement, enabling it to refine future drug designs based on prior experience. By showcasing the potential of LLM-powered multi-agent systems in drug discovery, this work establishes a new paradigm for autonomous, explainable, and scalable pharmaceutical research, with future extensions toward comprehensive drug lifecycle management.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoveryLanguage ModelingLanguage ModellingLarge Language ModelSimilar Papers 제목 키워드 기반
JEDEL: Zero-Shot DNA-Encoded Library Design for Early-Stage Drug Discovery
We present JEDEL, a framework for generating synthesis-ready DNA-encoded libraries (DELs) directly from three-dimensional pharmacophore representations of active ligands. JEDEL is the first model to map pharmacophore int…
Drug DiscoveryPharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling
As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening methods have been developed for rapid sc…
Drug DiscoveryGraph MatchingInstance SegmentationPose Prediction+1PharmacoMatch: Efficient 3D Pharmacophore Screening via Neural Subgraph Matching
The increasing size of screening libraries poses a significant challenge for the development of virtual screening methods for drug discovery, necessitating a re-evaluation of traditional approaches in the era of big data…
Contrastive LearningDrug DiscoveryHuman-Level and Beyond: Benchmarking Large Language Models Against Clinical Pharmacists in Prescription Review
The rapid advancement of large language models (LLMs) has accelerated their integration into clinical decision support, particularly in prescription review. To enable systematic and fine-grained evaluation, we developed …
Pharmacophore-based design by learning on voxel grids
Ligand-based drug discovery (LBDD) relies on making use of known binders to a protein target to find structurally diverse molecules similarly likely to bind. This process typically involves a brute force search of the kn…
Drug Discovery